Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06610396 · ClinicalTrials.gov registry record

Ex Onc SLED: a Study Utilizing a Weighted Sled for Horizontal Resistance Training

A clinical trial of Cancer, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Recruiting
Registry status
30
Enrollment target
1
Study location

NCT06610396: Recruiting study of Cancer, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

NCT06610396 is a study of Cancer that is actively recruiting participants, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 30 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06610396, a study of Cancer, is actively recruiting participants, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

This protocol seeks to analyze patient adherence and outcomes after monitored exercise sessions utilizing primarily weighted sled pushes and pulls for linearly progressed resistance training of individuals who have been diagnosed with cancer.

Primary Outcome

Change in adipose tissue (kg) pre and post resistance training regimen measured via InBody 970 bioelectrical impedance analysis

Conditions Studied

Cancer

Study Locations (1)

Pennsylvania

  • Allegheny General Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-06-18
Est. Completion 2026-09-18
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

34 total trials

What NCT06610396 shows while recruiting

NCT06610396 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT06610396 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06610396 about?

NCT06610396 is a clinical study titled "Ex Onc SLED: a Study Utilizing a Weighted Sled for Horizontal Resistance Training". This protocol seeks to analyze patient adherence and outcomes after monitored exercise sessions utilizing primarily weighted sled pushes and pulls for linearly progressed resistance training of individuals who have been diagnosed with cancer.

What is the current status of trial NCT06610396?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2024-06-18. Estimated completion is 2026-09-18.

What conditions does trial NCT06610396 study?

This clinical trial studies the following conditions: Cancer.

Who is sponsoring clinical trial NCT06610396?

This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06610396 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06610396's enrollment target sits among peer trials

30 502nd of 615 higher than 93 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06610396

Source: ClinicalTrials.gov NCT06610396, the US trial registry maintained by the National Library of Medicine. NCT06610396 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.